Jacobson Center for Clinical & Translational Research

Main Menu

/research/

Additional Information

 

Contact Us

Gynecology Research

Study Title:  A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of Elagolix in Subjects with Moderate to Severe Endometriosis-Associated Pain (Identifier: NCT01931670)

Study Purpose:  A randomized study evaluating the safety and efficacy of elagolix in the management of moderate to severe endometriosis-associated pain in adult premenopausal female subjects.

Principal Investigator: Ronica Neuhoff, M.D.

Study Coordinator: Stephanie Smiddy, RN, CRC For more information, please contact 419.383.6794


Study Title:  A Phase 2b Study to Evaluate the Safety and Efficacy of Elagolix in Premenopausal Women With Heavy Menstrual Bleeding Associated With Uterine Fibroids (Identifier: NCT01817530)

Study Purpose:   This is a Phase 2b randomized, double-blind, placebo-controlled study evaluating the safety and efficacy of elagolix alone and in combination with add-back therapy versus placebo on heavy menstrual bleeding in premenopausal women 18 to 51 years of age with uterine fibroids.

Principal Investigator: Ronica Neuhoff, M.D.

Study Coordinator: Stephanie Smiddy, RN, CRC For more information, please contact 419.383.6794

Last Updated: 6/17/14